J&J touts spinal pain, stiffness improvements with Tremfya




J&J touts spinal pain, stiffness improvements with Tremfya | Seeking Alpha


























The hands of a man with psoriatic arthritis on a wooden table.

Jacques Hugo

  • Johnson & Johnson (JNJ) said that phase 4 data on Tremfya (guselkumab) showed that the IL-23 antagonist led to significant reductions in pain, stiffness, swelling, and fatigue in patients with psoriatic arthritis and axial involvement.
  • At week 24 of the



Source link

Keto diet slashes liver fat by 67% in just 4 months

Megyn Kelly Calls Leonardo DiCaprio a ‘Disgusting Bloated Mess’

Leave a Reply

Your email address will not be published. Required fields are marked *